Rivulet Media Inc (fka RIVU)

[PeterGates]

A CLOSER look at the yesterday's PR:

Dr. Koos stated following in the PR:

As part of the clinical trial approval process, the FDA will issue comments on the proposed trial which must be addressed to the FDA's satisfaction before patient dosing is initiated.

It sounds like FDA is trying to comment on patient criteria s than the application itself meaning FDA seems to be inclined towards GO AHEAD signal.

Also Why assign a IND number if they are going to reject? I would like to know from investors how was the case with the companies where IND was rejected? Was there a assigned IND number??

Dr. Koos also sounded optimistic and a step forward when he said

" We have compiled an internationally-renowned team, consisting of corporate and academic partners, which cover the manufacturing, regulatory, and medical aspects of the project."

I think the next positive PR will definitely shoot this PPS above 5 cents. JMHO.......